Minutes of the CAT meeting 17-19 July 2024

Orphan designation: Anti-CD123 IgG1 humanised monoclonal antibody conjugated to N1-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl)-N6-((S)-1-(((S)-1-((3-((((S)-8-methoxy-6-oxo-11,12,12a,13-tetrahydro-6H-benzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)-5-((((S)-8-methoxy-6-oxo-12a,13-dihydro-6Hbenzo[5,6][1,4]diazepino[1,2-a]indol-9-yl)oxy)methyl)phenyl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)adipamide,pivekimab sunirine Treatment of blastic plasmacytoid dendritic cell neoplasm, 26/06/2020 Positive

Minutes of the CAT meeting 19-21 June 2024

Orphan designation: camrelizumab Treatment of hepatocellular carcinoma, 25/07/2024 Positive

Orphan designation: [(2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-pyridin-2-ylhepta-2,4-dien-2-yl]-1-oxacyclododec-4-en-6-yl]4-methylpiperazine-1-carboxylate Treatment of myelodysplastic syndromes, 20/06/2023 Positive

Minutes of the CAT meeting 22-24 May 2024

Orphan designation: Glycyl-L-2-methylprolyl-L-glutamic acid,trofinetide Treatment of Rett syndrome, 10/08/2015 Positive

UPD registration guide for UI and API users

Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, substantial modification, non-substantial modification

Big data training curriculum